Sight Sciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Sight Sciences Inc 's inventory turnover ratio, the ratio that measures Sight Sciences Inc 's ability to manage its supply chain, sequentially decreased to 1.38 in the first quarter 2026, which does not come as a surprise, as the Sight Sciences Inc continue to experience headwinds, which also impact its supply chain. Sight Sciences Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 264 days, from 253 days, in the Dec 31 2025 quarter.

Within Healthcare sector 274 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the fourth quarter 2025, to 1727.

SGHT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sight Sciences Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SGHT Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	20.71 %	22.8 %	31.08 %	-8.36 %	-15.51 %
Y / Y Cost of Sales Growth	0 %	33.33 %	-33.33 %	-33.33 %	0 %
Inventory Turnover Ratio (TTM)	1.38	1.44	1.37	1.64	1.76
SGHT's Total Ranking	# 1727	# 0	# 1100	# 904	# 1182
Average inventory processing period	264	253	267	223	207
Seq. Inventory Growth	-9.78 %	-2.72 %	28.48 %	7.05 %	-8.22 %
Seq. Cost of Sales Growth	-50 %	100 %	0 %	0 %	-33.33 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 126
Healthcare Sector	# 275
Overall Market	# 1727

Inventory Turnover Ratio Statistics
High	Average	Low
2.97	1.86	1.25
(Dec 31 2021)		(Mar 31 2024)

SGHT Company Profile >> Back to SGHT Efficiency Comparisons >> Compare SGHT Inventory Turnover Ratio to its Competitors

Financial Statements
Sight Sciences Inc 's Inventories	$ 7 Millions	Visit SGHT's Balance sheet
Sight Sciences Inc 's Cost of Revenues TTM	$ 10 Millions	Visit SGHT's Income Statement
What are SGHT's Sales?		Visit SGHT's Sales by Segment

Other Inventory Turnover Ratios
Sight Sciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SGHT's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SGHT's Competitors
Inventory Turnover Ratio for SGHT's Suppliers
Inventory Turnover Ratio for SGHT's Customers

You may also want to know
SGHT's Sales Growth Rates	SGHT's Pe Price to earnings ratio	SGHT's Receivables Turnover Ratio	SGHT's Stock Quote
SGHT's Net Income Growth Rates	SGHT's Ps Price to Sales ratio	SGHT's Sales per Employee	SGHT's Asset Turnover Ratio
SGHT's Net Margin	SGHT's Pb Price to Book ratio	SGHT's Financial Strength Ratios	SGHT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Iridex Corp	3.92	$ 32.247 Millions	$ 8 Millions
Myomo Inc	3.88	$ 14.000 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.84	$ 71.976 Millions	$ 19 Millions
Escalon Medical Corp	3.79	$ 6.698 Millions	$ 2 Millions
Evolus Inc	3.71	$ 103.000 Millions	$ 28 Millions
Abbvie Inc	3.70	$ 18,420.000 Millions	$ 4,975 Millions
Alpha Teknova Inc	3.69	$ 26.248 Millions	$ 7 Millions
Biocryst Pharmaceuticals Inc	3.67	$ 19.884 Millions	$ 5 Millions
Neuraxis Inc	3.61	$ 0.665 Millions	$ 0 Millions
Mirum Pharmaceuticals Inc	3.50	$ 85.221 Millions	$ 24 Millions
Sonoma Pharmaceuticals Inc	3.46	$ 12.114 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.45	$ 461.746 Millions	$ 134 Millions
Exelixis Inc	3.41	$ 84.478 Millions	$ 25 Millions
Baxter International Inc	3.37	$ 7,911.000 Millions	$ 2,348 Millions
Gilead Sciences Inc	3.36	$ 6,139.000 Millions	$ 1,825 Millions
Maravai Lifesciences Holdings Inc	3.33	$ 143.875 Millions	$ 43 Millions
Intelligent Bio Solutions Inc	3.31	$ 2.064 Millions	$ 1 Millions
Agilent Technologies inc	3.29	$ 3,418.000 Millions	$ 1,038 Millions
Cadre Holdings inc	3.28	$ 372.000 Millions	$ 113 Millions
Solventum Corporation	3.23	$ 3,363.000 Millions	$ 1,042 Millions
Biofrontera Inc	3.22	$ 8.867 Millions	$ 3 Millions
10x Genomics Inc	3.21	$ 193.000 Millions	$ 60 Millions
Iovance Biotherapeutics inc	3.14	$ 165.941 Millions	$ 53 Millions
Lftd Partners Inc	3.12	$ 28.258 Millions	$ 9 Millions
Prestige Consumer Healthcare Inc	3.11	$ 493.000 Millions	$ 159 Millions
Beyond Air Inc	3.07	$ 6.521 Millions	$ 2 Millions
Bausch Health Companies Inc	3.07	$ 2,987.000 Millions	$ 974 Millions
Indivior Pharmaceuticals Inc	3.03	$ 242.000 Millions	$ 80 Millions
Amneal Pharmaceuticals Inc	3.02	$ 1,868.000 Millions	$ 618 Millions
Logicmark Inc	3.01	$ 3.826 Millions	$ 1 Millions

Date modified: 2026-08-30T15:02:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.